Tobacco Use clinical trials
37 active trials name this condition. Describe your situation to see which ones you may be eligible for.
By location
- Neural Mechanisms Connecting Deficient Sleep and Smoking Relapse
- Trial of a Harm Reduction Strategy for People With HIV Who Smoke Cigarettes
- Integrating CHWs Into Prenatal Care for Maternal Smoking Cessation
- Feasibility and Acceptability Trial to Reduce Tobacco and Cannabis Use During Pregnancy and Postpartum
- Reach Through Equitable Implementation in Utah
- STEPS: Substance Use Trial of E-cigarettes or Pharmacotherapy for Smoking
- A Study of Exercise and Pharmacologic Intervention on Systemic Inflammation
- Human Laboratory Study of the Effects of Nicotine Product Claims on Appeal, Perceptions, and Use Behavior
- THRIVE Study: Understanding How Oral Nicotine Pouches Affect Public Health
- Social Media Influences on Engagement and Susceptibility to Non-combustible Tobacco Product Use Among Youth and Young Adults (AYA)
- Lung Macrophage Populations and Functions in Chronic Obstructive Pulmonary Disease (COPD)-Susceptible Smokers
- Little Cigar Oxidants
- Attitudes and Perceptions Attitudes and Smoking Perceptions in the Real Environment -II
- Neural Correlates and Behavioral Impact of Withdrawal-induced Hyperalgesia Among People Who Smoke With and Without Chronic Pain
- Cardiovascular Effects of Very Low Nicotine Content Cigarettes
- Impact of Semaglutide on Tobacco Use and Related Health Behaviors
- Influence of Authorized Smokeless Tobacco Product Modified Risk Claims II: Laboratory Assessment of Sensory and Subjective Effects
- Effect of Cannabis on Cigarette Use Behavior
- Understanding the Clinical Pharmacology of Marijuana-Tobacco Co-administration
- Cigar Legislation and Regulation in Tobacco for the Young (Project CLARITY)
- Effect of Cannabis on E-Cigarette Use Behavior
- Opioids, Low Nicotine Cigarettes, and Chronic Pain
- A Mindfulness-based Intervention for Sexual Assault Survivors
- Lung Health and Breath Biomarkers: Acute Effects of Inhaled Cannabis
- Impact of Electronic Cigarette Temperature and Solvent on Biomarkers
- Novel Labels to Improve Public Understanding of the Nicotine in Electronic Nicotine Delivery Systems: A Survey of Nicotine Concentration and Nicotine Flux
- Quit and Screen Project
- Responses of Adults Smoking Nondaily and Daily in the Experimental Tobacco Marketplace
- Persistent Poverty Counties Pregnant Women With Medicaid
- Modeling Tobacco Regulatory Impacts in Appalachia Using the Experimental Tobacco Marketplace
- Understanding Vape Marketing Study
- An Evaluation of the Tobacco Prevention Toolkit Healthy Futures: Alternative-to-Suspension Vaping Intervention
- Enhancing Equity in Smoke-free Housing
- CONNECT Cancer Survivors With Tobacco Treatment
- Developing a Positive Approach to Substance Use Prevention in North American Indian Adolescents
- Salvation Army Tobacco Quit Line Referral Implementation Trial
- Effects of Relighting on Smoke Toxicant Deliveries and Subjective Smoking Measures
Guides for people searching for a trial
- Why people get turned down — and what to do nextWhat eligibility criteria are for, what keeps people out, and where to go when the first door closes.
- How your biomarkers decide which trials you qualify forEGFR, HER2, BRAF, PD-L1 and the rest — what they are and why they increasingly gate access.
- How to search for a trial without losing your mindWhere to look, what to gather first, and how to read what you find.
- What Phase 1, 2 and 3 actually mean for youWhat each phase is testing, and how to weigh an early-phase trial against a later one.
- 10 questions to ask before you say yesTreatment, time, cost, safety and your rights. Worth bringing to a screening visit.
- You matched with a trial. What happens now?Phone screens, the screening visit, informed consent, and day one.
Showing active trials that list “Tobacco Use” as a condition. Eligibility shown on each trial is an estimate — the trial's study team makes the final decision.